Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Amortizatization of Intangibles (2020 - 2025)

Precision Biosciences (DTIL) has disclosed Amortizatization of Intangibles for 6 consecutive years, with -$464000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 175.45% to -$464000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$457000.0, a 693.51% decrease, with the full-year FY2024 number at $249000.0, down 32.34% from a year prior.
  • Amortizatization of Intangibles was -$464000.0 for Q3 2025 at Precision Biosciences, down from $318000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $615000.0 in Q3 2024 to a low of -$793000.0 in Q4 2023.
  • A 5-year average of $168578.9 and a median of $306000.0 in 2022 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: plummeted 351.75% in 2023, then surged 1196.55% in 2025.
  • Precision Biosciences' Amortizatization of Intangibles stood at $319000.0 in 2021, then decreased by 1.25% to $315000.0 in 2022, then tumbled by 351.75% to -$793000.0 in 2023, then rose by 21.69% to -$621000.0 in 2024, then increased by 25.28% to -$464000.0 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Amortizatization of Intangibles are -$464000.0 (Q3 2025), $318000.0 (Q2 2025), and $310000.0 (Q1 2025).